NCT00507702终止不适用
Identification of Key Blood Molecular Markers for Immunotherapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 191
- 试验地点
- 1
- 主要终点
- To identify and evaluate the presence of pre-existing immunity related markers in peripheral human blood, to identify patients who may respond to IL-12 immunotherapy
研究概览
简要总结
To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with cancerous tumors based on biopsy or other clinical observations.
- •Patients diagnosed with non-cancerous tumors based on biopsy or other clinical observations.
- •Normal volunteers who do not have cancer or other medical conditions that may affect survival.
排除标准
- •Patients will be excluded if, upon clinical observation, they are under a severe septic or inflammatory condition. In these conditions, human body immune response against sepsis or inflammation should be the predominant response, and may shield or block the immune response against tumors.
- •Patients will be excluded if, upon clinical observation, they are under extremely illness situation like myocardial infarction. In such a case, the immune findings may be altered.
- •Patients will be excluded if, upon looking through their medical records, significant information required for data analysis is missing. This is because that patients' medical records will help us connect our research findings with their clinical observations, and further provide guidelines for subsequent treatment options.
结局指标
主要结局
To identify and evaluate the presence of pre-existing immunity related markers in peripheral human blood, to identify patients who may respond to IL-12 immunotherapy
时间窗: 3 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast DiseaseBreast CancerNCT00898508City of Hope Medical Center563
已完成
不适用
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid LeukemiaLeukemiaNCT00897182Alliance for Clinical Trials in Oncology96
招募中
不适用
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")Stage III Solid TumorsStage IV Solid TumorsNCT05692466Glendale Adventist Medical Center d/b/a Adventist Health Glendale572
招募中
不适用
Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")Stage III Solid TumorsStage IV Solid TumorsNCT05703243Glendale Adventist Medical Center d/b/a Adventist Health Glendale572
已完成
不适用
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsLung CancerNCT00899028Vanderbilt University Medical Center689